Yuneec Not Too Unique – Latest Drone Firm to Lay Off Staff

Yuneec is following within the footsteps of 3DR and Parrot, amongst others. Like them, Yuneec is experiencing a spherical of layoffs because the drone business seeks stronger traction in each the industrial and shopper markets.

Marketwatch is reporting that the drone producer  confirmed on Friday that it could lay off an undisclosed variety of staff in its Americas division. Marketwatch quotes the corporate as stating, “scale back our business structure to a secure balance between operational costs and revenue,” in accordance to an announcement issued by Yuneec. “We concluded that we upsized operations faster than our growth required.” Yuneec is the most recent in a collection of drone firms to announce layoffs.

Yuneec, which has acquired funding from Intel, isn’t distinctive in ratcheting up manufacturing for a market that has not but materialized. DJI seems to be the one shining instance that to date is immune from the financial pressures of a slowly creating market. The open query that is still is why so many corporations received their projections fallacious. There could also be a number of causes not the least of which could possibly be an lack of ability of governments to enact laws that may safely allow the business. Training and price are all the time obstacles to entry of a brand new expertise; however on this case regs (or lack thereof) may be enjoying an element.

Frank Schroth is editor in chief of DroneLife, the authoritative supply for information and evaluation on the drone business: it’s individuals, merchandise, developments, and occasions.
Email Frank
Previous Canada Enacts New Safety Rules for Recreational Drone Use
Next FLIR CEO on the Black Hornet and Thermal Imaging for Drones

Check Also

DJI Air 3S leaks take flight as the drone king braces for lo…

The prospect of a ban on DJI drones in the US doesn’t appear to have …

The Download: Replacing animal testing, and underwater drone…

Animal studies are notoriously bad at identifying human treatments. Around 95% of the drugs developed …